Is a metabolic enzyme complex involved in the efficient and accurate control of Ipecac alkaloid biosynthesis in Psychotria ipecacuanha?

Ipecac alkaloids produced in the medicinal plant Psychotria ipecacuanha such as emetine and cephaeline possess a monoterpenoid-tetrahydroisoquinoline skeleton, which is formed by condensation of dopamine and secologanin. The condensation products are deglucosylated, and the resulting aglycon is further processed to protoemetine, which is condensed with the second molecule of dopamine, followed by conversion into cephaeline and emetine. Although four hydroxy groups derived from two molecules of dopamine need to be methylated to form emetine, the order of O-methylation reactions had been veiled. We recently identified three Ipecac alkaloid O-methyltransferases (IpeOMT1-IpeOMT3) that are sufficient for catalyzing O-methylations of all four hydroxy groups. Detailed characterization of their catalytic properties with integration of that of the previously identified Ipecac alkaloid β-glucosidase (IpeGlu1) revealed a large portion of the biosynthetic pathway of Ipecac alkaloids. The results provide proof-of-concept to the significance and the usefulness of the biosynthetic pathway strategy by EST analysis coupled with recombinant enzyme characterization. At the same time, however, the results raised an intriguing question about the subcellular network between the biosynthetic enzymes and intermediates. Here, we provide additional discussion about this point, and indicate what remains to be elucidated.